Thursday, January 16, 2020
"From Reefer Madness to Hemp Utopia: CBD, Hemp and the Evolving Regulation of Commoditized Cannabis"
The title of this post is the title of this exciting event taking place next week put on by the Drug Enforcement and Policy Center at The Ohio State University. Here are all the essential details and some background from this page where you can also find a registration link:
When: Friday, January 24 from 7:30-9:30 a.m.
Where: 2nd Floor Rotunda, Mason Hall, 250 W Woodruff Avenue, Columbus Ohio
Join the Drug Enforcement and Policy Center and the Center for Innovation Strategies for From Reefer Madness to Hemp Utopia: CBD, Hemp and the Evolving Regulation of Commoditized Cannabis. The latest Cannabiz Roundtable discussion will feature a panel of experts as they discuss the challenges of regulating the unusual agricultural commodity that is hemp and the myriad products infused with one of its derivatives, CBD.
With the passage of the 2018 Farm Bill, the world of the cannabis plant has undergone a seismic shift allowing for its legal cultivation as long as its THC content remains below 0.3%. A year later, the federal and state governments, including the state of Ohio, are in the process of creating regulations that would allow the agricultural sector to take advantage of this new crop while at the same time addressing numerous concerns about public health and law enforcement.
Benton Bodamer, DEPC Adjunct Faculty, Dickinson Wright PLLC, Columbus
Donnie Burton, Owner and CEO, The Harvest Foundation
David E. Miran, Jr. Esq., Executive Director, Hemp Program, Ohio Department of Agriculture
Anthony Seegers, Director of State Policy, Ohio Farm Bureau
Patricia Zettler, DEPC Assistant Professor of Law, Moritz College of Law
Moderator: Douglas Berman, Executive Director, DEPC
7:30 – 8:00 a.m. | registration
8:00 – 9:00 a.m. | panel
9:00 – 9:30 a.m. | follow up conversation and networking
January 16, 2020 in Business laws and regulatory issues, Federal Marijuana Laws, Policies and Practices, Medical Marijuana Commentary and Debate, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Monday, January 13, 2020
As detailed on this US House committee webpage, the "Subcommittee on Health of the Committee on Energy and Commerce will hold a legislative hearing on Wednesday, January 15, 2020, at 10 a.m. in the John D. Dingell Room, 2123 of the Rayburn House Office Building. The hearing is entitled, 'Cannabis Policies for the New Decade'." Interestingly, the hearing page provides a list and links to six House bills with varying approaches to marijuana reform as well as the names and titled of the three government officials now scheduled to testify:
H.R. 171, the "Legitimate Use of Medicinal Marihuana Act" or the "LUMMA"
H.R. 601, the "Medical Cannabis Research Act of 2019"
H.R. 1151, the "Veterans Medical Marijuana Safe Harbor Act"
H.R. 2843, the "Marijuana Freedom and Opportunity Act"
H.R. 3797, the "Medical Marijuana Research Act of 2019"
H.R. 3884, the "Marijuana Opportunity Reinvestment and Expungement Act of 2019" or the "MORE Act of 2019"
Matthew J. Strait
Senior Policy Advisor, Diversion Control Division
Drug Enforcement Administration
Douglas Throckmorton, M.D.
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research
Food and Drug Administration
Nora D. Volkow, M.D.
Director, National Institute on Drug Abuse
National Institutes of Health
Also listed on the website is a "Key Document" in the form of a "Memorandum from Chairman Pallone to the Subcommittee on Health." This memo runs six pages and provides a nice primer on the basics of federal cannabis law as well as a very brief accounting of the six bills listed above.
January 13, 2020 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, Medical Marijuana Commentary and Debate, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Friday, January 10, 2020
The question in the title of this post is promoted by this CNN Business piece which asserts in its headline "2020 could be a defining year for the cannabis industry." I find myself a bit skeptical because it seems someone says every January that this year is going to be a defining one for marijuana reform. But I do think there are reasons to see 2020 as an especially big year in this space, and here is part of the article:
2019 was a momentous year for the cannabis industry: Hemp-derived CBD had a heyday, Illinois made history, California got sticky, vapes were flung into flux, and North American cannabis companies received some harsh wake-up calls.
2020 is gearing up to be an even more critical year. There's a well-worn saying in the cannabis business that the emerging industry is so fast-moving that it lives in dog years. 2020 is barely a week old, and cannabis is already making headlines after Illinois kicked off the new year with recreational sales. Other states are inching closer to legalization this year -- with several mulling how best to ensure social equity. Also in 2020, there's the FDA could chill the CBD craze, and a move from Congress could change the game entirely....
Illinois will remain in focus, after it made history last year with the first legislatively-enacted recreational cannabis program. Critical aspects of its program include social equity and social justice measures created to help people and communities most harmed by the War on Drugs. "Underserved groups are holding the industry accountable," said Gia Morón, president for Women Grow, a company founded to further the presence of women in the cannabis industry. "And our legislators are recognizing that [social, gender and minority concerns] are a part of this now."
New York and New Jersey have been flirting with legalization but have held off to navigate some logistics related to aspects that include social equity. The governors of New York, New Jersey, Connecticut and Pennsylvania convened this past fall for a summit on coordinating cannabis and vaping policies. New Jersey is putting a recreational cannabis measure before voters in November, and Gov. Andrew Cuomo vowed Wednesday that New York would legalize cannabis this year....
CBD products have been all the rage, but they may be on shaky ground. CBD oils, creams, foods and beverages have seen an explosion in availability following the passage of the 2018 Farm Bill, which legalized hemp but left plenty of discretion to the US Food and Drug Administration, which regulates pharmaceutical drugs, most food items, additives and dietary supplements.
The FDA is reviewing CBD and has yet to issue formal guidance, although the agency has issued warning letters to CBD makers that make unsubstantiated health claims. Class action lawsuits have been filed against several CBD companies, including two of the largest, Charlotte's Web and CV Sciences, alleging they engaged in misleading or deceptive marketing practices, Stat News reported.
Cannabis insiders are closely awaiting the fate of industry-friendly bills such as the STATES Act, which would recognize cannabis programs at the state level, and the SAFE Banking Act, which would allow for banks to more easily serve cannabis companies. Those and other bills likely won't pass in full...
In addition to the promise of new markets, the evolution of established cannabis programs could also play a significant role in the cannabis business landscape. In California, the world's largest cannabis industry has developed in fits and starts. Regulators are taking aim at an entrenched illicit market as businesses decry tax increases and local control measures that limit distribution....
Canada's "Cannabis 2.0" roll-out of derivative products -- such as edibles, vapes and beverages -- is in its beginning stages. The Canadian publicly traded licensed producers that have been beset by missed and slow market development have bet heavily on these new product forms....
The capital constraints are expected to continue into the first leg of 2020 as some initial bets don't pan out for some companies, said Andrew Freedman, Colorado's former cannabis czar who now runs Freedman & Koski, a firm that consults with municipalities and states navigating legalization. Some companies' low points could create opportunities for other firms and investors that waited out the first cycle, Freedman said. "In 2020, I see that everybody will understand the economics of cannabis a little bit better," he said.
I am with Andrew Freedman in thinking that the realities of marijuana reform and the industry will, at best, become just "a little bit" clearer during 2020. In the end, I think what will matter most is who wins the White House and control of Congress in this big election year. If the status quo holds after the votes are counted, I do not expect to see federal reform anytime soon. But if new leadership takes over the White House or the Senate, then 2021 will become real interesting.
January 10, 2020 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, History of Marijuana Laws in the United States, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Wednesday, January 8, 2020
Is rooting for Bengals or Browns a sign of insanity or really just a medical marijuana qualifying condition?
I moved to central Ohio from the east coast in 1997. I had my reasons to start following the Cincinnati Bengals upon first arriving in the Buckeye state (I grew up in Maryland in the 1980s and formed a connection with Boomer Esiason). And I could not help but also be keen on the Cleveland Browns when the team returned to action in 1999. But, fast forward 23 years, and I have not seen either of Ohio's professional football teams even manage to win a single playoff game over this very long period. (Do not feel too bad for me, the OSU Buckeyes have given me plenty of victories to savor.)
Why do I tell this familiar tale of sporting woe in this space. Well, this amusing Cincinnati Enquirer article, headlined "Bengals, Browns seasons got you down? Medical marijuana proposed as treatment," reports on why it is relevant to the work of marijuana reform in the Buckeye state:
Long-suffering Bengals and Browns fans know the pain of defeat — over and over again. At least one person thinks they should be able to treat that misery with medical marijuana.
A petition to make "Bengals/Browns Fans" an official medical marijuana condition was submitted last month to the State Medical Board of Ohio.
Don't get your hopes up: It probably won't go anywhere. The board requires information from experts who specialize in studying the condition, relevant medical or scientific evidence and letters of support from doctors.
The board could not provide more information Monday about the petition, including who submitted it and their argument for why the board should add the "condition."
Last year, more than 100 petitions for new conditions were submitted. Those were winnowed to five: anxiety, autism spectrum disorder, depression, insomnia and opioid use disorder. All five were rejected by the board.
This time around, the board received 28 petitions. The latest batch includes conditions already approved in Ohio, such as chronic pain and PTSD. Petitions were again submitted for the conditions rejected last year. Repeat petitions must include new "scientific information" to be considered again.
Rob Ryan, who heads pro-cannabis coalition Ohio Patient Network, re-submitted a petition for opioid use disorder but he doesn't expect a different outcome. Ryan, who lives in Blue Ash and sometimes roots for the Bengals, didn't have a strong opinion of the football fan condition idea. "Maybe they should sell marijuana as well as beer at the stadium," Ryan said, chuckling. "It might calm the crowd down." But he hopes his proposal has a better shot.
Medical board attorneys will review the petitions to determine whether they meet the minimum requirements, such as including letters from supporting physicians. A medical board committee plans to decide in February which conditions will be reviewed by experts and voted on by the board later this year.
Sunday, January 5, 2020
This lengthy local article, headlined "Marijuana prosecutions in Texas have dropped by more than half since lawmakers legalized hemp," reports on a remarkable new reality for Texas marijuana prosecutions. Here are some excerpts:
It’s been more than six months since Texas lawmakers legalized hemp and unintentionally disrupted marijuana prosecution across the state. Since then, the number of low-level pot cases filed by prosecutors has plummeted. Some law enforcement agencies that still pursue charges are spending significantly more money at private labs to ensure that substances they suspect are illegal marijuana aren't actually hemp.
The Texas Department of Public Safety and local government crime labs expect to roll out a long-awaited testing method to distinguish between the two in the next month or so. But that's only for seized plant material. There's still no timeline for when they will be able to tell if vape pen liquid or edible products contain marijuana or hemp. And DPS said even when its testing is ready, it doesn’t have the resources to analyze substances in the tens of thousands of misdemeanor marijuana arrests made each year — testing it didn’t have to do before hemp was legalized....
In June, Gov. Greg Abbott signed into law a widely supported bill to legalize hemp in Texas. The bill focused on agriculture practices and regulations, but it also narrowed the state’s definition of marijuana from cannabis to cannabis that contains more than 0.3% of tetrahydrocannabinol, or THC, the ingredient in marijuana that gets you high. Anything with less THC is hemp.
Lawmakers were warned the measure could bring marijuana prosecution to a halt without more resources because public labs could only determine whether THC was present in a substance, not how much was present. Still, the legislation sailed into law with no crime lab funding attached. State leaders and the bill authors have since reaffirmed that the law did not in any way decriminalize marijuana.
Soon after its passage, however, district and county prosecutors across the state, in counties that lean both Republican and Democratic, began dropping hundreds of low-level pot cases. Some began requiring law enforcement agencies to submit lab results proving the suspected drugs had more than 0.3% THC before they accepted cases for prosecution. The Texas District and County Attorneys Association advised its members that such testing likely is needed to prove in court that a substance is illegal....
In 2018, Texas prosecutors filed about 5,900 new misdemeanor marijuana possession cases a month, according to data from the Texas Office of Court Administration. The first five months of 2019 saw an average of more than 5,600 new cases filed a month. But since June, when the hemp law was enacted, the number of cases has been slashed by more than half. In November, less than 2,000 new cases were filed, according to the court data.
For those who support marijuana legalization, that change is welcome, adding to an already growing effort in some of the state’s most populated counties to divert pot smokers from criminal prosecution or not arrest them at all. “It means that there are fewer Texans that are getting slapped with a criminal record for marijuana possession, something that is already legal in other states,” said Katharine Harris, a drug policy fellow at Rice University’s Baker Institute for Public Policy.
Tuesday, December 31, 2019
As reported in this local article, "On the day before recreational cannabis becomes legal in Illinois, Gov. J.B. Pritzker announced he was pardoning more than 11,000 people who had been convicted of low-level marijuana crimes." Here is more:
“When Illinois’ first adult use cannabis shops open their doors tomorrow, we must all remember that the purpose of this legislation is not to immediately make cannabis widely available or to maximize product on the shelves, that’s not the main purpose, that will come with time,” Pritzker said to a crowd at Trinity United Church of Christ on the Far South Side. “But instead the defining purpose of legalization is to maximize equity for generations to come.”
Pritzker, who has touted the social equity elements of the recreational pot law he signed this summer, was joined Tuesday by state, county and local leaders including Cook County State’s Attorney Kim Foxx, who has already begun the process of clearing the records of those with low-level marijuana convictions in her jurisdiction.
The 11,017 people pardoned by Pritzker will receive notification about their cases, all of which are from outside Cook County, by mail. The pardon means convictions involving less than 30 grams of marijuana will be automatically expunged.
Pritzker and other elected officials said they believe Illinois is the first state to include a process for those previously convicted of marijuana offenses to seek relief upon legalization of cannabis. “This is justice,” said Lt. Gov. Juliana Stratton. “And this is what equity is all about, righting wrongs and leveling the playing field.”...
Officials estimate there are hundreds of thousands of people with marijuana-related convictions in Illinois who could be eligible for relief. Those with criminal convictions can get a copy of their criminal record and start the process, though many of the cases will be automatically expunged by the state in the next couple of years.
The Illinois State Police are searching criminal records to identify eligible cases, which are then sent to the state’s Prisoner Review Board. After the board reviews the cases, the names of those eligible for relief are sent to the governor’s office to be considered for pardon. After Pritzker issues the pardon, the attorney general’s office automatically files petitions on the person’s behalf to expunge the records.
State’s attorney offices across the state are also being notified of eligible cases, which can then be vacated by a local judge. In Cook County, prosecutors are working with California-based Code for America to search for convictions involving less than 30 grams of cannabis. Those cases have resulted in both misdemeanor and Class 4 felony convictions....
Individuals with cases involving 30 to 500 grams of cannabis can also be eligible for relief, but the process won’t be automatic, instead requiring the person to file motions to vacate the conviction, according to the governor’s office.
While a pardon forgives a conviction, an expungement erases it from the public record. When a judge vacates a conviction, it overturns it as if it never happened. When a case is expunged, the case is hidden from public view, but it could be viewed by law enforcement if they obtained a court order.
Many of the elected officials noted that enforcement of marijuana-related offenses have disproportionately affected minorities. The Rev. Michael Pfleger, of St. Sabina Church on the South Side, said the elected officials on the stage had done their job, but it would be up to business leaders in the new industry to provide financial mobility for those individuals. “Employ these individuals," Pfleger said to the crowd. “Give them a job.”
Ald. Walter Burnett Jr., of the 27th Ward, noted that a pardon for an armed robbery conviction decades ago changed his life and allowed him to serve in public office. He invoked Martin Luther King Jr.'s words to describe how he felt when his record was expunged and how others might feel when they hear news of the pardons. “Free at last,” Burnett said. “Free at last. Thank God almighty, they are free at last.”
December 31, 2019 in Criminal justice developments and reforms, History of Marijuana Laws in the United States, Race, Gender and Class Issues, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Tuesday, December 24, 2019
The title of this post is the clever title of this interesting new report from California's Legislative Analyst's Office released last week. (Hat top: Crime & Consequences.) Here is part of the report's "Executive Summary":
Proposition 64 (2016) directed our office to submit a report to the Legislature by January 1, 2020, with recommendations for adjustments to the state’s cannabis tax rate to achieve three goals: (1) undercutting illicit market prices, (2) ensuring sufficient revenues are generated to fund the types of programs designated by the measure, and (3) discouraging youth use. This report responds to this statutory requirement and discusses other potential changes to the state’s cannabis taxes. While this report focuses on cannabis taxes, nontax policy changes also could affect these goals.
Proposition 64 established two state excise taxes on cannabis. The first is a 15 percent retail excise tax, effectively a wholesale tax under current law. The second is a tax based on the weight of harvested plants, often called a cultivation tax. (The measure authorizes the Legislature to amend its tax provisions without voter approval, but the scope of this authorization is unclear.)...
We analyze four types of taxes: basic ad valorem (set as a percentage of price, such as the current retail excise tax), weight-based (such as the current cultivation tax), potency-based (for example, based on tetrahydrocannabinol [THC]), and tiered ad valorem (set as a percentage of price with different rates based on potency and/or product type). Our analysis focuses primarily on three main criteria: (1) effectiveness at reducing harmful use, (2) revenue stability, and (3) ease of administration and compliance. No individual type of tax performs best on all criteria. For example, tiered ad valorem and potency-based likely are best for reducing harmful use, but basic ad valorem is easiest to administer. Given these trade-offs, the Legislature’s choice depends heavily on the relative importance it places on each criterion. That said, the weight-based tax is generally weakest, performing similarly to or worse than the potency-based tax on the three main criteria....
Any tax rate change would help the state meet certain goals while likely making it harder to achieve others. On one hand, for example, reducing the tax rate would expand the legal market and reduce the size of the illicit market. On the other hand, such a tax cut would reduce revenue in the short term, potentially to the extent that revenue could be insufficient. Furthermore, lower tax rates could lead to higher rates of youth cannabis use. With a thriving illicit market, however, much of the cannabis used by youth could avoid taxation. Where possible, this report provides quantitative estimates of the short-term effects of rate changes....
We view reducing harmful use as the most compelling reason to levy an excise tax. Accordingly, we recommend that the Legislature replace the existing retail excise tax and cultivation tax with a potency-based or tiered ad valorem tax, as these taxes could reduce harmful use more effectively. If policymakers value ease of administration and compliance more highly than reducing harmful use, however, the Legislature might prefer to keep the existing retail excise tax. In contrast, we see little reason for the Legislature to retain the weight-based cultivation tax....
If the Legislature decides not to adopt a potency-based or tiered ad valorem cannabis tax, we nevertheless recommend that the Legislature eliminate the cultivation tax. In this case, we recommend that the Legislature set the retail excise tax rate somewhere in the range of 15 percent to 20 percent depending on its policy preferences.
December 24, 2019 in Recreational Marijuana Commentary and Debate, Recreational Marijuana Data and Research, Recreational Marijuana State Laws and Reforms, Taxation information and issues , Who decides | Permalink | Comments (0)
Friday, December 13, 2019
Eight Senators (all Dems) write to federal agencies inquiring about efforts to advance medical marijuana research
This webpage with the heading "Senators Request Update from Federal Agencies on Progress Towards Issuing Long-Delayed Licensing of Marijuana Manufacturing for Research Purposes" reports on a notable new letter from some federal lawmakers. Here are the basics:
United States Senators Elizabeth Warren (D-Mass.), Ron Wyden (D-Ore.), Kamala Harris (D-Calif.), Kirsten Gillibrand (D-N.Y.), Cory Booker (D-Conn.), Jeff Merkley (D-Ore.), Edward J. Markey (D-Mass.), and Jacky Rosen (D-Nev.) sent a letter to the U.S. Department of Health and Human Services (HHS), the Drug Enforcement Administration (DEA), and the White House Office of National Drug Control Policy (ONDCP), requesting an update on the progress of the federal government's efforts to facilitate research on medical marijuana by issuing needed manufacturing licenses. The senators seek guidance on how the DEA will make these licenses available to qualified researchers in a timely manner given that the federal government has a unique responsibility to coordinate medical marijuana research efforts -- and has delayed issuing these licenses in the past.
"With millions of American adults having access to recreational marijuana and a growing number seeking the drug for medicinal purposes, the federal government is not providing the necessary leadership and tools in this developing field," wrote the lawmakers. "Evidence-based public policy is crucial to ensuring our marijuana laws best serve patients and health care providers."
The lawmakers have requested responses no later than January 10, 2020, to better understand both the DEA's decision-making, and its work with HHS and ONDCP to expand medical marijuana research. "This research is crucial to developing a thorough understanding of medical marijuana and would be invaluable to doctors, patients, and lawmakers across the nation," wrote the lawmakers.
The full letter is available at this link, and it starts this way:
We write to inquire about your respective agencies' ongoing efforts with regard to scientific research on the potential health and therapeutic benefits of marijuana when used for medical purposes ("medical marijuana"). In light of the Drug Enforcement Administration's (DEA) most recent announcement that it will issue additional marijuana manufacturing licenses for research purposes — an announcement that comes three years after a similar yet unfulfilled DEA commitment — we are also requesting written guidance on how the DEA will make these licenses available to qualified researchers in a timely manner.
Wednesday, December 11, 2019
As reported in this press release, yesterday the National Cannabis Roundtable (NCR) "pledged its commitment to fostering social justice, equity, and diversity in the cannabis industry [through] the launch of NCR’s Corporate Social Responsibility program." Here is more from the release:
Looking to do their part to reduce the negative impact of the War on Drugs, specifically in those communities disproportionately affected by it, NCR members will commit time, talent and financial resources to pursue social justice measures, equity in business and diversity and inclusion within member companies. More information about NCR’s Corporate Social Responsibility Pledge can be found here.
“We are not just having a conversation about how the cannabis industry can benefit those most impacted by decades of discriminatory drug policy, we are taking action,” said Dr. Chanda Macias, MBA, Ph.D., Owner of NHHC, and First Vice Chair of NCR. “It is critically important to the future success of cannabis in America that we build justice and equity into the very fabric of this burgeoning industry.”
Some states with legal cannabis, including Massachusetts, California, and most recently Illinois, have developed social equity programs through their license structure, but no state has pushed businesses to take a reflective look at their own operations. NCR’s Corporate Social Responsibility program is our members’ effort to address that void and to ensure real outcomes with regard to justice, equity and diversity and inclusion.
NCR Executive Director Saphira Galoob said that members will begin 2020 assessing their internal practices – providing a baseline look at where they are today through the goals and activities outlined in the social responsibility pledge while developing targets for greater impact within their own operations. “Our members are passionate about promoting social responsibility in this fast-growing industry,” said Saphira Galoob, NCR Executive Director. “NCR is proud to bring cannabis into the mainstream and harness its potential to benefit our communities.”
NCR will engage subject matter experts from minority, adversely impacted, and designated beneficiary communities to advise the organization on the effectiveness and impact of CSR. These subject matter experts will work with NCR members and staff to ensure the integrity of the program and to measure performance and accountability.
The full five-page NCR Corporate Social Responsibility Pledge can be viewed at this link here, and it makes for an interesting read. The document sets forth three "Core Values" labeled as "Social Justice" and "Social Equity" and "Diversity and Inclusion in Business." The document then sets out four "pillars of equal importance ... meant to provide a baseline for all participants in NCR." These pillars are "1) Criminal Justice; 2) Equity in Business Opportunity; 3) Jobs & Employment; 4) Health Education and Health Disparities."
Writing in Forbes, Mike Adams has this amusing commentary under the headline ""Federal Marijuana Legalization Is A Lock – But How, When?". Here are excerpts:
Although pro-pot groups insist that 2019 has been the best year ever in the realm of cannabis reform, the reality is not much progress has transpired. It is only revered as the “best year” because even less occurred in the years that came before it. But no matter how you size it up, nothing plus bupkis still equals squat. In spite of everything, marijuana remains illegal across most of the United States.
At the state level, many advocates predicted that New York and New Jersey would be the next to legalize weed. Well, that didn’t happen. In fact, Illinois swooped in and legalized first, making both states look like dorks. But aside from that, no other significant pot laws were passed at the state level in 2019. We also learned that police are still out there arresting more than 600,000 pot offenders nationwide every year — mostly small timers, too.
In addition, some states, like California, are having trouble curbing the black market, and tainted pot products, most of which were initially believed to be counterfeits, are finding their way into legal dispensaries. To make matters worse, the cannabis industry, as a whole, is struggling to keep it together long enough to see profitability. Layoffs are prevalent and some of the nation’s most popular cannabis magazines are at risk of going under. There’s just no possible way that 2019 should be considered a banner year for cannabis.
Federally speaking, parts of Congress dilly-dallied around with the notion of forging some kind of change in the realm of national cannabis reform, but the powers against it are still too strong to penetrate. Rumor has it that the cannabis trade’s legislative pride and joy known as the SAFE Act is presently being gnawed on by rats in the basement of the Senate chamber. Its last words were reportedly, “Y’all know I’m not really a marijuana bill, right?” And the MORE Act, the proposal that got everyone to stop giving two-flying squirts about SAFE, well, that sucker has already been buried out behind the Capitol building alongside last year’s great green hope, the STATES Act. Remember that one? No? Don’t feel bad, no one does. No one cares. The point is that cannabis hopefuls have spent all year yapping about legislation that doesn’t have what it takes to go the distance.
But the stakes are about to change in 2020, which could set the nation up for legal weed the following year. There’s only one catch. Americans – 66 percent of which are on board with legalizing the leaf the same as beer and tobacco – have to vote in the next election. And for the right people.
The first thing all cannabis hopefuls need to come to grips with is that the SAFE Act and the MORE Act are dead. No, that’s not official or anything. There hasn’t been a press release issued saying that Senate Majority Leader Mitch McConnell and his Republican-dominated Senate are refusing to entertain these bills before year’s end. But trust me on this one – SAFE and MORE are finished.
They could, however, be resurrected in 2020. But for either of them to get any further attention, the legislative process would have to start from the very beginning. And unless the Republicans in the Senate have a change of heart in the next few months, the prospect of getting these bills or any others aimed at legalizing weed nationwide isn’t going much further next year than they did in 2019. Remember, as of January, Congress is still playing with the same losing team.
It is the November election when all the magic could happen. It’s a time when the stoner stars could align and contribute to getting America high again. But that all depends on the nation’s political loyalty when it comes time to vote. There are several Senate seats up for grabs. It is conceivable that the Democrats could win these seats and take control over the Senate. If that happens, McConnell, the man presently standing in the way of cannabis reform in the U.S, would be dethroned as Senate Majority Leader. That’s when the cannabis debate could really find its footing in both chambers. Because there would no longer be anyone on the Hill that cares enough to try to stop it. And anyone who did oppose would surely be out voiced by Democratic rule.
Furthermore, a Democratic president (except for Joe Biden) would undoubtedly support most cannabis legislation, and there is even a solid chance that President Trump would sign off on it if he wins a second term. Unless, of course, Trump decides to make a statement by stamping it with a veto just to prevent the Democrats (the same ones trying to have him impeached) from making any progress. Grudges tend to have an extremely long shelf life when it comes to politics.
But here’s the deal. If both Trump and the Democrats find success in the next election, the best-case scenario for getting marijuana legalization done at the federal level in 2021 is for Trump to make it his idea and let the Democrats follow suit.
December 11, 2019 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Wednesday, November 20, 2019
US House Judiciary Committee advances sweeping marijuana reform bill, the MORE Act, by a vote of 24-10
As report in this press piece, headlined "House panel passes bill aiming to legalize marijuana, but top Democrat concedes ‘Senate will take its own time,’" a notable marijuana reform bill advanced in Congress today, but its long-term prospects are still limited. Here are the basics:
The Democratic-controlled House Judiciary Committee on Wednesday voted in favor a bill that decriminalizes marijuana at the federal level, with a couple of Republicans supporting the measure.
The panel’s chairman, however, had acknowledged Tuesday that the Marijuana Opportunity Reinvestment and Expungement (MORE) Act could be a tough sell in the Republican-controlled Senate. “The Senate will take its own time, but then the Senate always does,” said Jerry Nadler, the New York Democrat. He aimed to sound upbeat during Tuesday’s news conference ahead of Wednesday’s markup session for the bill: “The energy and the political pressure from the various states is growing rapidly. The Senate is subject to that, too. We’ll accomplish this.”...
Nadler, for his part, had on Tuesday described the committee vote on the MORE Act as “part of a long-term fight.” He stressed Wednesday that House lawmakers can negotiate with the Senate. Pro-marijuana activists have been celebrating the action in the House Judiciary Committee, with the National Organization for the Reform of Marijuana Laws, also known as NORML, calling it the “biggest marijuana news of the year” and the “first-ever vote to remove marijuana from the Controlled Substances Act.”
Besides decriminalizing marijuana at the federal level, the MORE Act aims to expunge prior marijuana convictions and spur re-sentencing hearings for people still under supervision. It also would set up a 5% sales tax on marijuana products that would fund three grant programs, including one that would provide job training, legal aid and other services to the individuals hit hardest by the War on Drugs....
The MORE Act [available here] has more than 50 co-sponsors in the House, including Republican Rep. Matt Gaetz of Florida, a member of the House Judiciary Committee who voted for the measure on Wednesday. The backers of the bill in the Senate include Democratic presidential hopefuls Sen. Kamala Harris of California, Sen. Cory Booker of New Jersey and Sen. Elizabeth Warren of Massachusetts.
The House committee voted 24-10 in favor of the bill on Wednesday, a House clerk said. Georgia Rep. Doug Collins, the committee’s top Republican, was among the GOP lawmakers who didn’t support the measure.
Collins said the MORE Act was a non-starter for most of his Republican colleagues. He suggested it won’t become law and lead to real change. “Do we want to accomplish something or do we just want to make a political statement?” Collins asked.
Groups in Washington that have disclosed lobbying on the MORE Act this year include the National Association of Mutual Insurance Companies (NAMIC), the Cannabis Trade Federation, the National Association of Criminal Defense Lawyers, the American Civil Liberties Union and NORML.
The cannabis industry has set a fresh record for its overall annual lobbying spending in Washington, with an outlay of $3.77 million through this year’s third quarter as it has pushed for a bill that would protect financial institutions that work with the marijuana industry.
As reported in this Politico piece, headlined "New Jersey marijuana legalization bill dead; lawmakers will let voters decide," legislators in the Garden State have failed again to achieve significant marijuana reforms through the traditional legislative process and now have a new 2020 plan. Here are the details and backstory:
For the second time this year, top Democratic lawmakers in New Jersey pulled the plug on legislation to legalize cannabis sales for recreational use, killing any likelihood Gov. Phil Murphy will deliver on a key campaign promise before 2021.
Instead, legislative leaders introduced a resolution Monday that would put a recreational use question on the November 2020 ballot. The resolution would need to pass both houses of the state Legislature by three-fifths majorities in one year or by simple majorities in consecutive years to make it onto the ballot.
“We made further attempts to generate additional support in the Senate to get this done legislatively, but we recognize that the votes just aren’t there. We respect the positions taken by legislators on what is an issue of conscience," Senate President Steve Sweeney said in a joint statement with Sen. Nicholas Scutari (D-Union), who had been the lead sponsor of the cannabis legalization bill, NJ S2703 (18R), in the upper house....
Murphy, who campaigned heavily on a pro-cannabis platform in 2017, was disappointed by the announcement, but said in a statement he has “faith that the people of New Jersey will put us on the right side of history when they vote next November.“ “By approving this ballot measure before the end of this legislative session, New Jersey will move one step closer to righting a historical wrong and achieving what I have spent more than three years advocating for,” the governor said.
Several polls released over the last two years suggest a solid majority of New Jersey residents support marijuana legalization. Even so, NJ RAMP —an affiliate of the anti-legalization group Smart Approaches to Marijuana — has already said it plans to fight the measure at the ballot box.
Should voters approve the referendum, it would be up to the Legislature to take action to grant oversight of the adult use industry to the Cannabis Regulatory Commission, which was previously established through medical marijuana legislation passed earlier this year....
Monday’s announcement marks the conclusion of a long odyssey for the Democrat’s recreational use bill, which was originally scheduled for a vote in March after months of protracted negotiations between Murphy, Sweeney and Assembly Speaker Craig Coughlin. That vote was scuttled after Sweeney and Murphy failed to whip up the necessary 21 votes in the upper house. A majority of Assembly members supported the bill.
Two months later, amid an escalating feud between Murphy and South Jersey Democratic power broker George Norcross over tax incentives, Sweeney said there wasn’t a viable path forward for the bill’s passage, laying some blame on the administration’s efforts to unilaterally expand New Jersey’s medical marijuana program.
Sweeney reversed course several months later, saying he’d like to give the legislation another shot with some technical revisions to accommodate regulatory changes established through the state’s new medical marijuana law, NJ A20 (18R), along with criminal justice reforms that have since been included in subsequent legislation. Both bills had previously been linked to the fate of recreational use legislation.
Tuesday, November 19, 2019
US House Judiciary Committee to hold mark up of MORE Act proposing federal decriminalization of marijuana on Nov 20
As detailed in this press release, "House Judiciary Committee Chairman Jerrold Nadler (D-NY) [Monday] announced the Committee will hold a markup on Wednesday, November 20, 2019 of H.R. 3884, the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act), comprehensive legislation to decriminalize marijuana at the federal level, reassess marijuana convictions, and invest in local communities. Senator Kamala Harris (D-CA) introduced the companion bill in the Senate." Here is more about MORE moving forward legislatively:
Ahead of the markup, on Tuesday, November 19, 2019, Chairman Nadler, Rep. Barbara Lee (D-CA), Rep. Earl Blumenauer (D-OR) and additional Members of Congress, will hold a press conference to highlight the legislation.
"Our marijuana laws disproportionately harm individuals and communities of color, leading to convictions that damage job prospects, access to housing, and the ability to vote." said Chairman Nadler. "Recognizing this, many states have legalized marijuana. It’s now time for us to remove the criminal prohibitions against marijuana at the federal level. That’s why I introduced the MORE Act, legislation which would assist communities disproportionately impacted by the enforcement of these laws. I am grateful for the leadership of Rep. Barbara Lee and Rep. Blumenauer, as well as other Members of Congress who have helped pave the way for this important measure. I look forward to moving this legislation out of the House Judiciary Committee, making it one step closer to becoming law."
"Our federal cannabis policies have been rooted in the past for far too long. As states continue to modernize how we regulate cannabis, Congress has a responsibility to ensure that our policies are fair, equitable, and inclusive," said Congresswoman Lee. "As Co-Chair of the bipartisan Cannabis Caucus, I am pleased to see Chairman Nadler and the Judiciary Committee take this historic step in marking up the Marijuana Opportunity Reinvestment & Expungement (MORE) Act. I’m pleased that this critical bill includes key tenets from my own legislation to right the wrongs of the failed and racist War on Drugs by expunging criminal convictions, reinvesting in communities of color through restorative justice, and promoting equitable participation in the legal marijuana industry. I applaud Chairman Nadler for his leadership and look forward to seeing this bill move out of committee."
Tuesday Press Conference on MORE Act
Date: November 19, 2019
Time: 11:00 a.m.
Location: Rayburn House Office Building Room 2237, Washington, D.C. Live stream: https://www.facebook.com/HouseJudDems/
Wednesday Markup of the MORE Act
Date: November 20, 2019
Time: 10:00 a.m.
Location: Rayburn House Office Building Room 2141, Washington, D.C. Live stream: https://www.youtube.com/channel/UCVvv3JRCVQAl6ovogDum4hA
The Marijuana Opportunity Reinvestment and Expungement Act:
- Decriminalizes marijuana at the federal level by removing the substance from the Controlled Substances Act. This applies retroactively to prior and pending convictions, and enables states to set their own policy.
- Requires federal courts to expunge prior convictions, allows prior offenders to request expungement, and requires courts, on motion, to conduct re-sentencing hearings for those still under supervision.
- Authorizes the assessment of a 5% sales tax on marijuana and marijuana products to create an Opportunity Trust Fund, which includes three grant programs:
- The Community Reinvestment Grant Program: Provides services to the individuals most adversely impacted by the War on Drugs, including job training, re-entry services, legal aid, literacy programs, youth recreation, mentoring, and substance use treatment.
- The Cannabis Opportunity Grant Program: Provides funds for loans to assist small businesses in the marijuana industry that are owned and controlled by socially and economically disadvantaged individuals.
- The Equitable Licensing Grant Program: Provides funds for programs that minimize barriers to marijuana licensing and employment for the individuals most adversely impacted by the War on Drugs.
- Opens up Small Business Administration funding for legitimate cannabis-related businesses and service providers.
- Provides non-discrimination protections for marijuana use or possession, and for prior convictions for a marijuana offense:
- Prohibits the denial of any federal public benefit (including housing) based on the use or possession of marijuana, or prior conviction for a marijuana offense.
- Provides that the use or possession of marijuana, or prior conviction for a marijuana offense, will have no adverse impact under the immigration laws.
- Requires the Bureau of Labor Statistics to collect data on the demographics of the industry to ensure people of color and those who are economically disadvantaged are participating in the industry.
The full text of the MORE Act is available at this link. Based on my email traffic, I know a lot of marijuana reform groups are very excited about this legislative development. But I will await news that the full House will be voting on the bill, as well as some indication that the Senate might be interested in taking up any marijuana reform proposals, before thinking that federal reform is anywhere close to becoming a reality.
As noted in this prior post when the MORE Act was first introduced, I am excited that the most comprehensive federal marijuana reform bill to be getting attention includes a provision (Section 5) establishing a "Cannabis Justice Office" within the within the federal Office of Justice Programs. In my 2018 article, "Leveraging Marijuana Reform to Enhance Expungement Practices," I make the case for using marijuana revenues to help build an institutional infrastructure for helping to remediate the various harms from the war on drugs. Though this proposed Cannabis Justice Office is not exactly what I had in mind, I am thrilled to see a major reform bill focus on creating an infrastructure for continued emphasis on justice and equity issues.
Prior related post:
Tuesday, November 12, 2019
The question in the title of this post is the headline if this notable new editorial in the journal Drug Discovery Today authored by Patricia Zettler and Erika Lietzan. (Disclosure/humble brag: Professor Zettler is on the Ohio State College of Law faculty and a member of our Drug Enforcement and Policy Center.) Here are excerpts from the start and end of the piece:
In the last two years the cannabidiol (CBD) market has exploded. Consumers can purchase CBD-containing oils, lotions, gummies, tea, coffee, water, popcorn, and cereal, on store shelves and online. Celebrities and athletes are touting the benefits of these products, and sales are forecast to exceed $20 billion in the next five years. This market explosion has coincided with the U.S. Food & Drug Administration (FDA)’s 2018 approval of the first CBD drug (Epidiolex), for treating seizures associated with two rare and severe forms of epilepsy in children, as well as the 2018 Farm Bill, which removed cannabis with low levels of delta-9-tetrahydocannabinol (THC) — “hemp” — from the federal list of controlled substances. And it comes on the heels of nearly 40 states enacting comprehensive laws to legalize cannabis for medical use (and sometimes recreational use) within their borders.
Yet significant questions remain about the legal status of these widely available CBD products. Most sales of CBD-containing foods and supplements violate the “drug exclusion rules” in the Federal Food, Drug, and Cosmetic Act (FDCA). But FDA has yet to enforce those rules, apart from sending warning letters to a few sellers. The agency is instead considering what approach to take. Several former agency officials — including former Commissioner Scott Gottlieb — have urged FDA to create a sensible, science-based path forward for consumer products. The time is ripe for the agency, lawmakers, health care providers, the drug discovery community, and the public to consider the purpose of the drug exclusion rules and what a different approach — exempting CBD — might mean for consumer and patient access and safety, as well as innovation incentives....
As a practical matter, CBD-containing foods and supplements may be here to stay. Lawmakers or FDA may decide that the drug exclusion rules are unwarranted for CBD, given the federal descheduling of hemp, state legalization of cannabis products, and (eventually) rigorous evidence that CBD products are relatively safe. But FDA should not default into this position simply because a robust, albeit unlawful, market has already emerged. A decision to give CBD special treatment should be made thoughtfully and with public participation, accounting for possible gains in consumer access and choice, as well as the lost opportunity to learn, and harness, CBD’s full therapeutic potential.
November 12, 2019 in Business laws and regulatory issues, Federal Marijuana Laws, Policies and Practices, Medical community perspectives, Medical Marijuana Commentary and Debate, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Wednesday, November 6, 2019
The title of this post is the title of this new paper now available via SSRN authored by Rob Mikos. Here is its abstract:
The states have launched a revolution in marijuana policy, creating a wide gap between state and federal marijuana law. While nearly every state has legalized marijuana in at least some circumstances, federal law continues to ban the substance outright. Nonetheless, the federal response to state reforms has been anything but static during this revolution. This Essay, based on my Distinguished Speaker Lecture at Delaware Law School, examines how the federal response to state marijuana reforms has evolved over time, from War, to Partial Truce, and, next (possibly) to Capitulation. It also illuminates the ways in which this shifting federal response has alternately constrained and liberated states as they seek to regulate marijuana as they deem fit.
Tuesday, November 5, 2019
This new Politico piece reports on this interesting new polling that seems to me to present the deepest accounting of (shallow?) views on a range of cannabis related issues. Here is part of the Politico piece:
Americans now think marijuana is much less harmful than alcohol, tobacco or e-cigarettes, according to new polling results from POLITICO and Harvard’s T.H. Chan School of Public Health released Monday. Just 1 in 5 Americans believe marijuana is very harmful to people who use it. Twice as many said the same about alcohol, 52 percent characterized e-cigarettes as very harmful and 80 percent said tobacco cigarettes are very harmful....
The poll shows marijuana largely has avoided a perception hit following nearly 2,000 cases of vaping-related lung illnesses, including at least 37 deaths. The most recent numbers from the Centers for Disease Control and Prevention show that more than 80 percent of vaping products linked to lung problems contained THC — the psychoactive component of marijuana. Most of the vaping products tied to the outbreak were bought on the black market, although a handful of deaths have been tied to products purchased through state-legal marijuana dispensaries. The poll was conducted in early October, at least a month after news broke of health issues associated with vaping....
The market for CBD products has exploded since hemp was legalized under the 2018 farm bill, with Americans using it to treat everything from back pain to cancer. But despite widespread use, many Americans don't know what it is.
Nearly half of respondents indicated they weren’t familiar with CBD. Yet CBD is widely seen by the general public as a benign substance. Only 8 percent of total adults polled and 5 percent of those familiar with CBD said they think it is very harmful.
A majority of people familiar with CBD said they want little to no interference or regulation by the federal government. Only half of those who knew what CBD was thought the Food and Drug Administration should regulate the safety of products that contain it. The FDA is wrestling with how it should regulate the rapidly growing industry.
Of consumers familiar with CBD, 55 percent said they should be able to buy it over the counter if they think it‘s effective for them — whether or not a clinical trial has proven that it actually is. And more than 3 out of every 5 CBD users say they’d consider using their favorite products even if the FDA found that the product doesn’t actually help in the way it claims to....
While 67 percent of Democrats and 69 percent of independents support federal marijuana legalization, only 45 percent of Republicans are on board. That translates to 62 percent of Americans supporting federal legalization, a huge leap from the 44 percent of Americans who thought legalization was a good idea in 2009...
But when it comes to CBD, there is no partisan divide. According to the Harvard poll, 13 percent of Republicans and Democrats indicated they use CBD products. In addition, 83 percent of Democrats and 73 percent of Republicans think it should be sold in drugstores like CVS or Walgreens. The real CBD divide is generational: 21 percent of adults under 30 use it, versus 11 percent of adults over 65.
November 5, 2019 in History of Marijuana Laws in the United States, Medical Marijuana Commentary and Debate, Polling data and results, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Monday, November 4, 2019
The title of this post is the title of this notable new article authored by Robert Mikos and Cindy Kam. Here is its abstract:
Over the past two decades, a growing cadre of US states has legalized the drug commonly known as “marijuana.” But even as more states legalize the drug, proponents of reform have begun to shun the term “marijuana” in favor of the term “cannabis.” Arguing that the “M” word has been tainted and may thus dampen public support for legalization, policy advocates have championed “cannabis” as an alternative and more neutral name for the drug. Importantly, however, no one has tested whether calling the drug “cannabis” as opposed to “marijuana” actually has any effect on public opinion.
Using an original survey experiment, we examine whether framing the drug as “marijuana” as opposed to “cannabis” shapes public attitudes across a range of related topics: support for legalization of the drug, moral acceptance of its use, tolerance of activities involving the drug, perceptions of the drug’s harms, and stereotypes of its users. Throughout each of our tests, we find no evidence to suggest that the public distinguishes between the terms “marijuana” and “cannabis.” We conclude with implications of our findings for debates over marijuana/cannabis policy and for framing in policy discourse more generally.
Saturday, October 26, 2019
Though the direction of public polling is never a sure forecast of the direction of public policy, the rapid reform of marijuana laws at the state level in the US has move in sync with a rapid rise in public support for such reform. And, as detailed in this Gallup posting, headlined "U.S. Support for Legal Marijuana Steady in Past Year," polling this year suggests that support for marijuana legalization is not waning (but also not growing). Here are the details:
Americans' support for legalizing marijuana has held steady at 66% over the past year, after rising 30 percentage points between 2005 and 2018. The latest results are based on Gallup's annual Crime survey, conducted Oct. 1-13. Not only have 66% favored legalizing marijuana in the 2018 and 2019 Crime polls, but the same level of support was found in an intervening Gallup survey, conducted in May.
Gallup first asked about making marijuana use legal in 1969, when just 12% of Americans favored the proposal. Nearly a decade later, a 1977 survey found support had increased to 28%, but it held at about that level through 1995, finally surpassing 30% in Gallup's next measurement, in 2000. Since then, the percentage of Americans advocating legal marijuana usage has more than doubled, with support increasing significantly among all major subgroups.
As public opinion has become increasingly pro-marijuana, so has state policy. As of June, 11 states plus the District of Columbia have legalized recreational use of marijuana. Twenty-two other states allow the use of marijuana for medical purposes.
Majorities of most key subgroups now favor making marijuana legal, according to an analysis of the opinions of more than 3,500 adults asked the question in the three 2018-2019 Gallup surveys. There are essentially no meaningful differences in support for legal marijuana by gender, education, income, region and urban/suburban/rural residence -- between 60% and 70% of subgroup members within those categories favor legalization. Opinions do vary significantly according to partisanship and ideology, age and generation, race, and religiosity.
Americans on the left of the political spectrum are more likely than those on the right to favor making marijuana legal. However, the differences are greater by political ideology than by partisanship. Twenty-five points separate Democratic (76%) and Republican (51%) support for making marijuana legal, with independents (68%) near the national average.
In contrast, 82% of liberals versus 48% of conservatives want to see marijuana made legal, a 34-point difference. Conservatives are one of the few major subgroups expressing less-than-majority support for making marijuana legal. Moderates' opinions (72%) are closer to those of liberals than conservatives.
Generally speaking, younger adults are much more likely than older adults to favor legalizing marijuana. This includes 81% of adults under age 30 as well as 80% of the larger millennial generation subgroup, consisting of those born between 1980 and 2000. By contrast, less than half of senior citizens (49%) are in favor of decriminalizing marijuana, and the percentage is even lower -- 40% -- among adults born in 1945 or before. Baby boomers and members of Generation X are close to the national average in terms of wanting marijuana to be made legal, at 61% and 63%, respectively.
Majorities of major U.S. racial and ethnic subgroups endorse the legalization of marijuana, but blacks are more likely to hold this view than whites, while Hispanics show even less support. Americans who attend religious services on a weekly basis are among the subgroups least likely to say marijuana should be made legal, with just 42% in favor. That compares with more than three-quarters of those who seldom or never attend church (77%) and 63% of those who attend occasionally.
Americans have rapidly shifted to backing legal marijuana in the past decade after consistently expressing opposition for 40 years. It appears the increases in support have halted for the time being, with no change in the percentage favoring legalization over the past year. However, given generational differences in support for legalizing marijuana use, it is likely the percentage who endorse making marijuana use legal will continue to expand in the years ahead.
Even if support has leveled off for the time being, it remains solidly above the majority level, and has created a public opinion environment that is conducive to more states adopting pro-marijuana policies. Although most states now allow marijuana usage for medical if not recreational purposes, the drug remains illegal according to federal law.
Thursday, October 24, 2019
Senator Bernie Sanders puts forth details for his plan to legalize marijuana and repair harms of the drug war
In August, Senator Bernie Sanders released this extended plan detailing a wide array of criminal justice reform proposals. Unsurprisingly, one plank of his broader reform plan included a commitment to "legalize marijuana and vacate and expunge past marijuana convictions, and ensure that revenue from legal marijuana is reinvested in communities hit hardest by the War on Drugs." Today, as detailed on this campaign page, Senator Sanders has provided a lot more of his proposed particulars for marijuana reform and here are excerpts:
As president, Bernie will:
Legalize marijuana in the first 100 days with executive action by:
- Nominating an attorney general, HHS secretary, and administrator for the DEA who will all work to aggressively end the drug war and legalize marijuana
- Immediately issuing an executive order that directs the Attorney General to declassify marijuana as a controlled substance
- While Congress must aggressively move to end the war on drugs and undo its damage, as president Bernie will not wait for Congress to act. Passing legislation to ensure permanent legalization of marijuana
Vacate and expunge all past marijuana-related convictions.
- In a Sanders administration we will review all marijuana convictions - both federal and state - for expungement and re-sentencing. All past convictions will be expunged.
- Based on the California model, we will direct federal and state authorities to review current and past marijuana related convictions for eligibility. This review will include re-sentencing for all currently incarcerated with marijuana convictions. Following determination of eligibility or status, prosecutors will have one year to appeal or object, after which authorities will automatically expunge and vacate past marijuana convictions for all those eligible.
- Federal funding will be provided to states and cities to partner with organizations that can help develop and operate the expungement determination process, much like how California worked with Code for America....
Ensure that revenue from legal marijuana is reinvested in communities hit hardest by the War on Drugs, especially African-American and other communities of color. With new tax resources from legal marijuana sales, we will:
- Create a $20 billion grant program within the Minority Business Development Agency to provide grants to entrepreneurs of color who continue to face discrimination in access to capital.
- With this revenue we will also create a $10 billion grant program to focus on businesses that are at least 51% owned or controlled by those in disproportionately impacted areas or individuals who have been arrested for or convicted of marijuana offenses....
- Use revenue from marijuana sales to establish a targeted $10 billion USDA grant program to help disproportionately impacted areas and individuals who have been arrested for or convicted of marijuana offenses start urban and rural farms and urban and rural marijuana growing operations to ensure people impacted by the war on drugs have access to the entire marijuana industry....
- Create a $10 billion targeted economic and community development fund to provide grants to communities hit hardest by the War on Drugs.
Ensure Legalized Marijuana Does Not Turn Into Big Tobacco Big Tobacco is already targeting the marijuana industry for its profits. As president, Bernie will not allow marijuana to turn into Big Tobacco. He will:
- Incentivize marijuana businesses to be structured like nonprofits.
- We will provide resources for people to start cooperatives and collective nonprofits as marijuana businesses that will create jobs and economic growth in local communities.
October 24, 2019 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, History of Marijuana Laws in the United States, Who decides | Permalink | Comments (0)
Wednesday, October 23, 2019
The title of this post is the title of this new paper recently posted to SSRN and authored by Abby Graves, a recent graduate The Ohio State University Moritz College of Law. This paper is the fourteenth paper in an on-going series of student papers supported by the Drug Enforcement and Policy Center. (The thirteen prior papers in this series are linked below.) Here is this latest paper's abstract:
Marijuana has taken a long journey through the court of public opinion; from condemned fringe use in minority communities and by jazz musicians through the 20s and 40s, to its heyday in the 60s and 70s era of Woodstock and Bob Dylan, only to be villainized again in the 80s and 90s. Today, the public perception of marijuana is dawning a new era of acceptance, in no small part thanks to its normalization in rap music and white America’s embrace of men like Calvin Broadus, also known as Snoop Doggy Dogg. Modern popular culture has slowly changed the public perception of recreational marijuana use and paved the way for legalization. Social scientists have been able to link the lyrics in popular music to the attitudes in popular opinion, and this paper will focus on the influence of hip hop, gangsta rap, the cult of celebrity, and Snoop Dogg himself on modern legalization efforts and cannabusiness.
Prior student papers in this series:
- "The Canna(business) of Higher Education"
- "Marijuana Banking in New York and Around the US: 'Swim at Your Own Risk'"
- "Intellectual Property Survey: Cannabis Plant Types, Methods of Extraction, IP Protection, and One Patent That Could Ruin It All"
- "Marijuana in the Workplace: Distinguishing Between On-Duty and Off-Duty Consumption"
- "An Argument Against Regulating Cannabis Like Alcohol"
- "The State of Marijuana in The Buckeye State and Fiscal Policy Considerations of Legalized Recreational Marijuana"
- "Race Based Statutes at Play with Cannabis: Cultivating a Process for Weeding Out the Competition"
- "Tribal Cannabis: Balancing Tribal Sovereignty and Cooperative Enforcement"
- "Land of the Free, Home of the (Disgruntled) Brave: The Case for Allowing Veterans Access to Medical Marijuana"
- "Cannabidiol (CBD) in the Therapeutics Industry"
- "The Good, the Bad, and the Ugly: Why IRC § 280E Is Not the Industry Killer It Is Portrayed to Be"
- "Achieving Diversity in the Marijuana Industry: Should States Implement Social Equity into Their Regimes?"
- "Cannabis Legalization: Dealing with the Black Market"